Biovaxys Technology OTC Stock Forecast - Naive Prediction

Biovaxys Technology Additional Predictive Modules

Most predictive techniques to examine Biovaxys price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biovaxys using various technical indicators. When you analyze Biovaxys charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Biovaxys Technology is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Biovaxys Technology Corp value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Biovaxys Technology Naive Prediction Price Forecast For the 29th of January

Given 90 days horizon, the Naive Prediction forecasted value of Biovaxys Technology Corp on the next trading day is expected to be 0.16 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0001, and the sum of the absolute errors of 0.55.

Biovaxys Technology OTC Stock Forecast Pattern

Backtest Biovaxys Technology

Biovaxys Technology Price Prediction

Buy or Sell Advice

Biovaxys Technology Forecasted Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Biovaxys Technology otc stock data series using in forecasting. Note that when a statistical model is used to represent Biovaxys Technology otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Biovaxys Technology Corp. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Biovaxys Technology. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Biovaxys Technology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biovaxys Technology Corp. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.01 0.16 6.65 Details

Intrinsic Valuation Low Real High 0.01 0.14 6.63 Details

Bollinger Band Projection (param) Low Middle High 0.15 0.17 0.19 Details

Biovaxys Technology After-Hype Price Density Analysis

Biovaxys Technology Estimiated After-Hype Price Volatility

Biovaxys Technology OTC Stock Price Outlook Analysis

Notes

Biovaxys Technology Hype Timeline

Biovaxys Technology Corp is currently traded for 0.16. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Biovaxys is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.15%. %. The volatility of related hype on Biovaxys Technology is about 5408333.33%, with the expected price after the next announcement by competition of 0.16. About 19.0% of the company shares are held by company insiders. The book value of Biovaxys Technology was currently reported as 0.06. The company recorded a loss per share of 0.05. Biovaxys Technology Corp had not issued any dividends in recent years. The entity had 2:1 split on the 28th of April 2020. Assuming the 90 days horizon the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Biovaxys Technology to cross-verify your projections.

Biovaxys Technology Related Hype Analysis

Other Forecasting Options for Biovaxys Technology

For every potential investor in Biovaxys, whether a beginner or expert, Biovaxys Technology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biovaxys OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biovaxys. Basic forecasting techniques help filter out the noise by identifying Biovaxys Technology's price trends.

Biovaxys Technology Related Equities

Risk & Return

Correlation

Biovaxys Technology Market Strength Events

Biovaxys Technology Risk Indicators

Story Coverage note for Biovaxys Technology

Other Macroaxis Stories

Other Information on Investing in Biovaxys OTC Stock